MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  

AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis

IRVINE, Calif. – Oct  2, 2024 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA

IRVINE, Calif. – Apr 11, 2024 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress

IRVINE, Calif. – Apr 2, 2024 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos

IRVINE, Calif. – Feb 27, 2024 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

IRVINE, Calif. – Jan 5, 2024 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Moderate Keynote Panel of Pharma Industry Leaders at World Vaccine Congress EU

IRVINE, Calif. – Oct 13, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Participate in Keynote Panel and Deliver Talk at Festival of Biologics Europe

IRVINE, Calif. – Oct 9, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Announces Case Report Suggesting Positive Collateral Benefits in Systemic Lupus Erythematosus Achieved Through the Use of Its Dendritic Cell Vaccine Kit

IRVINE, Calif. – Sep 21, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe

IRVINE, Calif. – Sep 5, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead Awarded OC50 Honor by The Orange County Business Journal

IRVINE, Calif. – Jul. 7, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

  • 1
  • 2
  • 3
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.